Introduction: Transcatheter mitral valve replacement (TMVR) with the transapically delivered Tendyne
bioprosthesis is a less invasive therapeutic alternative for patients with severe
mitral regurgitation (MR) and high or prohibitive surgical risk. Initial studies have
shown favorable left ventricular (LV) remodeling after Tendyne TMVR. Though it is
known that chronic severe MR leads to left atrial (LA) remodeling, pulmonary hypertension
and right ventricular (RV) dysfunction, limited data exists on changes in RV function
and morphology after Tendyne TMVR.
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
Full access to the journal is a member benefit for SCCT Members, Login via the SCCT website to access all journal content.
Subscribe:
Subscribe to Journal of Cardiovascular Computed TomographyAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
Article info
Identification
Copyright
© 2022 Published by Elsevier Inc.